Maya D. Srivastava

860 total citations
32 papers, 683 citations indexed

About

Maya D. Srivastava is a scholar working on Immunology, Surgery and Oncology. According to data from OpenAlex, Maya D. Srivastava has authored 32 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Surgery and 6 papers in Oncology. Recurrent topics in Maya D. Srivastava's work include Immune Cell Function and Interaction (5 papers), Reproductive System and Pregnancy (5 papers) and Inflammatory Bowel Disease (4 papers). Maya D. Srivastava is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Reproductive System and Pregnancy (5 papers) and Inflammatory Bowel Disease (4 papers). Maya D. Srivastava collaborates with scholars based in United States and Pakistan. Maya D. Srivastava's co-authors include B. I. Sahai Srivastava, Ben H. Brouhard, Jack Lippes, Jerome H. Check, Alton L. Melton, Maureen M. Jonas, Antonio R. Pérez‐Atayde, Anita Srivastava, Irwin A. Schafer and Charles L. Hoppel and has published in prestigious journals such as Gastroenterology, Cancer Research and Journal of Allergy and Clinical Immunology.

In The Last Decade

Maya D. Srivastava

29 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maya D. Srivastava United States 14 221 167 125 85 79 32 683
L. Edward Clemens United States 14 182 0.8× 28 0.2× 306 2.4× 35 0.4× 64 0.8× 19 821
Christy Toms United Kingdom 11 487 2.2× 32 0.2× 141 1.1× 176 2.1× 50 0.6× 16 922
Patricia Cristofaro United States 11 159 0.7× 38 0.2× 171 1.4× 27 0.3× 95 1.2× 19 521
Sebastiano Sansano Switzerland 14 737 3.3× 36 0.2× 255 2.0× 76 0.9× 236 3.0× 21 1.2k
Miloš Marković Serbia 15 219 1.0× 32 0.2× 88 0.7× 71 0.8× 73 0.9× 50 610
Y Tendler Israel 15 76 0.3× 34 0.2× 148 1.2× 81 1.0× 171 2.2× 40 561
Alexandra dos Anjos Cassado Brazil 8 350 1.6× 21 0.1× 198 1.6× 45 0.5× 85 1.1× 9 724
Michael Filarsky Germany 12 234 1.1× 60 0.4× 277 2.2× 34 0.4× 341 4.3× 13 829
Jiao Tian China 15 114 0.5× 23 0.1× 162 1.3× 64 0.8× 87 1.1× 37 603
Kunhua Wang China 18 110 0.5× 38 0.2× 786 6.3× 65 0.8× 112 1.4× 43 1.1k

Countries citing papers authored by Maya D. Srivastava

Since Specialization
Citations

This map shows the geographic impact of Maya D. Srivastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maya D. Srivastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maya D. Srivastava more than expected).

Fields of papers citing papers by Maya D. Srivastava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maya D. Srivastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maya D. Srivastava. The network helps show where Maya D. Srivastava may publish in the future.

Co-authorship network of co-authors of Maya D. Srivastava

This figure shows the co-authorship network connecting the top 25 collaborators of Maya D. Srivastava. A scholar is included among the top collaborators of Maya D. Srivastava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maya D. Srivastava. Maya D. Srivastava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Check, Jerome H., et al.. (2024). Significant Palliative Benefits Following Therapy With Mifepristone for Advanced Treatment Resistant Small Cell Lung Cancer. Anticancer Research. 44(2). 659–664. 2 indexed citations
2.
Check, Jerome H., et al.. (2023). Lung Cancer – Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators. Anticancer Research. 43(3). 951–965. 8 indexed citations
3.
Check, Jerome H., et al.. (2020). Treatment With Mifepristone Allows a Patient With End-stage Pancreatic Cancer in Hospice on a Morphine Drip to Restore a Decent Quality of Life. Anticancer Research. 40(12). 6997–7001. 13 indexed citations
4.
5.
6.
7.
Srivastava, B. I. Sahai & Maya D. Srivastava. (2005). Establishment and characterization of SRIK-NKL: a novel CD8+ natural killer/T cell line derived from a patient with leukemic phase of acute lymphoblastic lymphoma. Leukemia Research. 29(7). 771–783. 2 indexed citations
8.
Melton, Alton L., et al.. (2005). Identification and quantification of innate immune system mediators in human breast milk.. PubMed. 25(5). 297–304. 75 indexed citations
9.
Srivastava, Maya D. & B. I. Sahai Srivastava. (2005). Expression of mRNA and proteins for toll-like receptors, associated molecules, defensins and LL-37 by SRIK-NKL, a CD8+ NK/T cell line. Leukemia Research. 29(7). 813–820. 5 indexed citations
10.
Srivastava, B. I. Sahai & Maya D. Srivastava. (2005). Expression of natural cytotoxicity receptors NKp30, NKp44, and NKp46 mRNAs and proteins by human hematopoietic and non-hematopoietic cells. Leukemia Research. 30(1). 37–46. 12 indexed citations
11.
Srivastava, Maya D., et al.. (2004). Mitochondrial Dysfunction in a Patient with Crohn Disease: Possible Role in Pathogenesis. Journal of Pediatric Gastroenterology and Nutrition. 38(5). 534–538. 1 indexed citations
12.
Srivastava, Maya D., et al.. (2004). Mitochondrial Dysfunction in a Patient with Crohn Disease: Possible Role in Pathogenesis. Journal of Pediatric Gastroenterology and Nutrition. 38(5). 534–538. 25 indexed citations
13.
García, Mónica, et al.. (2002). CASE REPORT: Efficacy of Early Immunosuppressive Therapy in a Child with Carbamazepine-Associated Vanishing Bile Duct and Stevens-Johnson Syndromes. Digestive Diseases and Sciences. 47(1). 177–182. 21 indexed citations
14.
Srivastava, Maya D., et al.. (2001). Elevated Serum Hepatocyte Growth Factor in Children and Young Adults With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 33(5). 548–553.
15.
Srivastava, Maya D., et al.. (2001). Elevated Serum Hepatocyte Growth Factor in Children and Young Adults With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 33(5). 548–553. 29 indexed citations
16.
Srivastava, Maya D., Jack Lippes, & B. I. Sahai Srivastava. (1999). Hepatocyte Growth Factor in Human Milk and Reproductive Tract Fluids. American Journal of Reproductive Immunology. 42(6). 347–354. 13 indexed citations
17.
Srivastava, Maya D., Antonio R. Pérez‐Atayde, & Maureen M. Jonas. (1998). Drug-associated acute-onset vanishing bile duct and Stevens–Johnson syndromes in a child. Gastroenterology. 115(3). 743–746. 58 indexed citations
18.
Srivastava, Maya D., Jack Lippes, & B. I. Sahai Srivastava. (1996). Cytokines of the Human Reproductive Tract. American Journal of Reproductive Immunology. 36(3). 157–166. 99 indexed citations
19.
Srivastava, Maya D., Anita Srivastava, & B. I. Sahai Srivastava. (1994). Soluble Interleukin-2 Receptor, Soluble CD8 and Soluble Intercellular Adhesion Molecule-1 Levels in Hematologic Malignancies. Leukemia & lymphoma. 12(3-4). 241–246. 16 indexed citations
20.
Srivastava, Maya D., Ravi Srivastava, & B. I. Sahai Srivastava. (1993). Constitutive production of interleukin-8 (IL-8) by normal and malignant human B-cells and other cell types. Leukemia Research. 17(12). 1063–1069. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Edward Clemens Breakdown of academic impact, for papers by Christy Toms Breakdown of academic impact, for papers by Patricia Cristofaro Breakdown of academic impact, for papers by Sebastiano Sansano Breakdown of academic impact, for papers by Miloš Marković Breakdown of academic impact, for papers by Y Tendler Breakdown of academic impact, for papers by Alexandra dos Anjos Cassado Breakdown of academic impact, for papers by Michael Filarsky Breakdown of academic impact, for papers by Jiao Tian Breakdown of academic impact, for papers by Kunhua Wang
Rankless by CCL
2026